International life sciences venture capital firm SV Life Sciences appointed Dr. Joshua Resnick as Partner.
Dr. Resnick, who will be based in SVLS’ Boston office, joined the firm’s biotech investment team which partners with experienced entrepreneurs and their management teams to develop innovative medicines, technologies and diagnostics that address significant, unmet needs in the medical, health and life sciences industries.
Dr. Resnick is a life sciences leader, entrepreneur, and investment professional with more than 15 years of experience in investing, company formation, and company leadership across all stages from discovery through commercialization.
Before joining SVLS, he was President and Managing Partner at MRL Ventures Fund. Prior to MRL Ventures, Dr. Resnick was a Venture Partner with Atlas Venture, focusing on company formation, seed and Series A investing. Prior to Atlas Venture, he was a Partner at Prism Venture Partners, where he focused on early-stage biopharmaceutical, medical device, tools and diagnostics investments.
SV Life Sciences is an international life sciences venture capital firm with a team of 35 professionals organized into three practice areas: Biotechnology, Medical Devices, and Healthcare Services and offices in Boston, London and San Francisco.